U1355 – RAMO-IT - Molecular Radiotherapy and Therapeutic Innovations
Transforming radiotherapy: toward precision medicine
Unit U1355/RAMO-IT (formerly “U1030”) develops an integrated research program aimed at profoundly transforming the use of radiotherapy in oncology. Historically based on standardized approaches, radiotherapy now faces major limitations related to the biological heterogeneity of tumors, variability in patient responses, and the occurrence of sometimes debilitating toxicities.
UMR 1186 - Integrative tumor immunology and immunotherapy
Our laboratory highlighted several constitutive elements of the tumor environment (TME) involved in the regulation of antitumor T-cell response, in particular:
Golan, T., Parikh, R., Jacob, E., Vaknine, H., Zemser-Werner, V., Hershkovitz, D., Malcov, H., Leibou, S., Reichman, H., Sheinboim, D., Percik, R., Amar, S., Brenner, R., Greenberger, S., Kung, A., Khaled, M., and Levy, C. (2019) Adipocytes sensitize melanoma cells to environmental TGF-beta cues by repressing the expression of miR-211. Sci Signal 12